Future Fields Analysis: $11M Raised
What is Future Fields?
Future Fields provides sustainable recombinant protein production using an insect-based expression system called EntoEngine. The company says its platform supports custom protein expression solutions for difficult-to-express proteins across life sciences, agriculture, and food innovation. Its site presents the company as a biology manufacturing provider serving biotech, agriculture, and food innovators.
Location
11130 105 Ave NW, Edmonton, Alberta T5H 0L5, Canada
Employees
11-50
Founded
2018
Revenue
$1.8M - $7.6M
Product Features & Capabilities
- EntoEngine™ platform, custom recombinant proteins, scalable protein production, genetic engineering for optimal yield, growth factors for cultivated meat media, human recombinant proteins for medical research, sustainable and ethical biomolecular tools.
Pricing
- Recombinant Human FGF2: From $92.00 USD
- Recombinant Bovine FGF2: From $110.00 USD
- Recombinant Human Prolactin, Fc Tag: From $105.26 USD
- Recombinant Human Prolactin: From $126.32 USD
- Recombinant Human Interleukin-2: From $125.48 USD
- Recombinant Human Interleukin-10: From $303.85 USD
- Recombinant Human PDGF-BB: $292.53 USD
- Recombinant E. coli BirA: From $294.45 USD
How much Future Fields raised
1 - $11.2M USD
February 22, 2023Lead Investor: Not specified in the source.
Who are the founders of Future Fields
MA
Matt Anderson-Baron
Co-Founder
JA
Jalene Anderson-Baron
Co-Founder
Market Focus
Future Fields primarily focuses on the biotechnology industry, specifically in advanced biomanufacturing and custom protein production using their EntoEngine™ platform, which utilizes fruit flies.
Investors
- Builders VC
- Climate Capital
- Green Circle Foodtech Ventures
- Toyota Ventures
- Haskayne
Competitors Overview
Future Fields operates in the biomanufacturing and protein production market, primarily utilizing fruit flies through their EntoEngine™ platform. The main competitors identified are:
-
Core Biogenesis:
- Overview: Based in Strasbourg, France, Core Biogenesis specializes in next-generation recombinant proteins for stem cell research and cell manufacturing.
- Advantages: They offer an Ultra-Scalable Biomanufacturing as a Service (UBaaS) platform, which is designed to benefit scientists by providing scalable solutions tailored to their needs.
-
Qkine:
- Overview: Located in Cambridge, Qkine focuses on manufacturing high-purity, animal-free growth factors, cytokines, and other complex proteins.
- Advantages: Qkine emphasizes sustainability and bioactivity, ensuring exceptional lot-to-lot consistency in their products. They operate in a dedicated animal-free laboratory, which appeals to clients looking for ethical and sustainable protein production.
-
Protera:
- Overview: Protera is known for its innovative approaches in protein design and production, although specific details about their operations were not retrieved in this search.
- Advantages: They are recognized for their advancements in synthetic biology, which may provide them with unique capabilities in protein engineering and production efficiency.
Notable differences include Future Fields' unique use of fruit flies for protein production, which may offer advantages in terms of sustainability and efficiency compared to traditional methods used by competitors.
See something that needs updating? Suggest edits to this profile.